Response rate of initial conventional treatments, disease course, and related factors of patients with adult-onset Still's disease: Data from a large multicenter cohort
Articles > Article · 2016
Authors: Umut Kalyoncu, Dilek Solmaz, Hakan Emmungıl, Ayten Yazıcı, Timucin Kasifoglu, Gezmis Kimyon, Ayse Balkarli, Cemal Bes, Mustafa Ozmen, Fatma Alibaz-Oner, Sukran Erten, Yonca Cagatay, Gozde Yildirim Cetin, Sedat Yılmaz, Fatih Yildiz, Omer Nuri Pamuk, Orhan Kucuksahin, Levent Kilic, Veli Yazisiz, Omer Karadag, Suleyman Serdar Koca, Mutlu Hayran, Servet Akar, Kenan AKSU, Nurullah Akkoc, Gökhan KESER, Emel Gonullu, Bunyamin Kisacik, Ahmet Mesut Onat, Mehmet Soy, Nevsun Inanc, Suzan GÜVEN, Mehmet Sayarlioglu, Eren Erken, Murat Turgay, Ayse Cefle, Ihsan Ertenli, Salih Pay
JOURNAL OF AUTOIMMUNITY, Journal Indexed in SCI Expanded, International, 2016, vol 69, pp 59-63
DOI: 10.1016/j.jaut.2016.02.010
Summary
Background: Adult-onset Still's disease (AOSD) is a rare condition, and treatment choices are frequently dependent on expert opinions. The objectives of the present study were to assess treatment modalities, disease course, and the factors influencing the outcome of patients with AOSD.